| Literature DB >> 35814881 |
Junya Izuhara1, Kazuki Kanayama1,2.
Abstract
Introduction: Liquid-based cytology (LBC) has been widely used since 2000. Next-Generation Sequencing (NGS) analysis of residual specimens in LBC fixative may also be performed for pancreatic cancer in the near future. We examined cell morphology, antigenicity and nucleic acids in pancreatic cancer cells at different fixation times using two types of LBC fixatives.Entities:
Keywords: Cell morphology; DNA fragmentation; immunocytochemical staining; liquid-based cytology; pancreatic cancer; real-time PCR
Year: 2022 PMID: 35814881 PMCID: PMC9261998 DOI: 10.4103/joc.joc_13_22
Source DB: PubMed Journal: J Cytol ISSN: 0970-9371 Impact factor: 1.577
Comparison of cell area of PANC-1 cells treated with various fixatives
| Fixation time | CytoRich Red | CytoRich Blue | 95% AL | 10% NBF | ||||
|---|---|---|---|---|---|---|---|---|
|
|
|
|
| |||||
| Mean±SD (μm2) | C.V. (%) | Mean±SD (μm2) | C.V. (%) | Mean±SD (μm2) | C.V. (%) | Mean±SD (μm2) | C.V. (%) | |
| 1 hour | 156.8±40.2 | 0.26 | 219.9±123.3 | 0.56 | 376.1±112.1 | 0.30 | 122.1±36.5 | 0.30 |
| 1 day | 148.1±37.8 | 0.26 | 186.9±56.4 | 0.30 | 295.5±91.9**** | 0.31 | 130.3±35.8 | 0.27 |
| 3 days | 146.8±36.3 | 0.25 | 201.2±77.1 | 0.38 | 266.5±91.5*** | 0.34 | 123.4±41.5 | 0.34 |
| 9 days | 150.1±36.9 | 0.25 | 152.5±40.3** | 0.26 | 142.2±32.8** | 0.23 | 127.4±34.3 | 0.27 |
| 14 days | 159.4±38.0 | 0.24 | 160.1±34.9* | 0.22 | 153.4±34.6* | 0.23 | 127.5±30.9 | 0.24 |
**** 1 hour vs. 1 day P<0.05. *** 1 hour vs. 3 days P<0.05. ** 1 hour vs. 9 days P<0.05. * 1 hour vs. 14 days P<0.05
Comparison of nuclear area of PANC-1 cells treated with various fixatives
| Fixation time | CytoRich Red | CytoRich Blue | 95% AL | 10% NBF | ||||
|---|---|---|---|---|---|---|---|---|
|
|
|
|
| |||||
| Mean±SD (μm2) | C.V. (%) | Mean±SD (μm2) | C.V. (%) | Mean±SD (μm2) | C.V. (%) | Mean±SD (μm2) | C.V. (%) | |
| 1 hour | 95.7±30.1 | 0.31 | 123.3±57.1 | 0.46 | 246.4±114.9 | 0.47 | 81.5±30.4 | 0.37 |
| 1 day | 93.3±29.8 | 0.32 | 108.7±52.2 | 0.48 | 197.5±96.1**** | 0.49 | 71.0±24.4 | 0.34 |
| 3 days | 81.3±26.7*** | 0.33 | 137.2±60.9 | 0.44 | 182.7±75.1*** | 0.41 | 67.6±26.9*** | 0.40 |
| 9 days | 86.0±28.8 | 0.33 | 86.2±37.7** | 0.44 | 89.6±36.0** | 0.40 | 70.5±19.8 | 0.27 |
| 14 days | 92.3±27.0 | 0.29 | 83.0±24.9* | 0.30 | 87.5±22.9* | 0.26 | 69.5±17.7 | 0.26 |
**** 1 hour vs. 1 day P<0.05. *** 1 hour vs. 3 days P<0.05. ** 1 hour vs. 9 days P<0.05. * 1 hour vs. 14 days P<0.05
Comparison of N/C ratio of PANC-1 cells treated with various fixatives
| Fixation time | CytoRich Red | CytoRich Blue | 95% AL | 10% NBF | ||||
|---|---|---|---|---|---|---|---|---|
|
|
|
|
| |||||
| Mean±SD (µm2) | C.V. (%) | Mean±SD (µm2) | C.V. (%) | Mean±SD (µm2) | C.V. (%) | Mean±SD (µm2) | C.V. (%) | |
| 1 hour | 0.59±0.11 | 0.19 | 0.64±0.12 | 0.19 | 0.76±0.10 | 0.13 | 0.57±0.10 | 0.18 |
| 1 day | 0.59±0.11 | 0.19 | 0.57±0.11**** | 0.20 | 0.75±0.11 | 0.15 | 0.55±0.10 | 0.17 |
| 3 days | 0.58±0.11 | 0.18 | 0.56±0.17*** | 0.30 | 0.70±0.09*** | 0.13 | 0.56±0.10 | 0.19 |
| 9 days | 0.56±0.09 | 0.17 | 0.52±0.10** | 0.19 | 0.58±0.10** | 0.17 | 0.54±0.08 | 0.16 |
| 14 days | 0.55±0.09 | 0.17 | 0.53±0.10* | 0.19 | 0.59±0.09* | 0.16 | 0.54±0.08 | 0.15 |
****1 hour vs. 1 day P<0.05. *** 1 hour vs. 3 days P<0.05. ** 1 hour vs. 9 days P<0.05. * 1 hour vs. 14 days P<0.05
Figure 1Comparison of p53 immunocytochemistry staining for samples with 1 hour and 14 days fixation. Cells fixed with (a) CytoRich Red or (b) CytoRich Blue for 1 hour; and cells fixed with (c) CytoRich Red or (d) CytoRich Blue for 14 days
Figure 2Comparison of CK20 immunocytochemistry staining for samples with 1 hour and 14 days fixation. Cells fixed with (a) CytoRich Red or (b) CytoRich Blue for 1 hour; and cells fixed with (c) CytoRich Red or (d) CytoRich Blue for 14 days
p53 positive rate of PANC-1 cells treated with various fixatives
| Fixation time | CytoRich Red Mean±SD (%) | CytoRich Blue Mean±SD (%) | 95% AL Mean±SD (%) | 10% NBF Mean±SD (%) |
|---|---|---|---|---|
| 1 hour | 89.5±3.2 | 40.3±5.9 | 33.2±3.1 | 91.8±2.3 |
| 1 day | 90.5±2.3 | 33.8±4.4 | 40.5±8.7 | 87.3±4.5 |
| 3 days | 89.1±5.8 | 30.0±3.3 | 37.2±8.0 | 81.2±4.9 |
| 9 days | 80.9±4.5 | 28.1±6.7 | 39.3±8.4 | 79.6±5.1 |
| 14 days | 82.7±3.9 | 61.5±5.7 | 55.6±12.7 | 86.5±3.0 |
CK20 positive rate of PACN-1 cells treated with various fixatives
| Fixation time | CytoRich Red Mean±SD (%) | CytoRich Blue Mean±SD (%) | 95% AL Mean±SD (%) | 10% NBF Mean±SD (%) |
|---|---|---|---|---|
| 1 hour | 97.9±2.0 | 93.6±2.1 | 88.5±4.7 | 96.1±2.4 |
| 1 day | 87.3±1.4 | 1.7±1.8 | 2.9±1.6 | 96.6±1.7 |
| 3 days | 86.9±3.2 | 2.3±2.6 | 6.2±4.5 | 95.5±3.0 |
| 9 days | 86.5±3.7 | 2.5±2.4 | 4.5±2.3 | 96.2±4.1 |
| 14 days | 84.8±2.4 | 2.3±2.7 | 29.7±12.5 | 98.0±1.2 |
Figure 3Nucleic acid yield extracted from 5 × 105 PANC-1 pancreatic cancer cells. PANC-1 cells were fixed in solution containing 95% ethanol, and 10% neutral buffered formalin with (a) CytoRich Red or (b) CytoRich Blue (3 samples per group)
Figure 4Real-time PCR amplification in a TaqMan Assay. Amplification with (a) Short Assay (87 bp) and (b) Long Assay (256 bp) was compared and the (c) relative ratio was calculated. Measurements were made triplicate for each sample